Gastric and colorectal cancers (GC and CRC) have poor prognosis and are resistant to
chemo-and/or radiotherapy. In the present study, the prophylactic effects of dendritic cell …

Dendritic cells (DCs) are potent antigen presenting cells that exist in virtually every tissue,
and from which they capture antigens and migrate to secondary lymphoid organs where …

Dendritic cells (DCs) can initiate and direct adaptive immune responses. This ability is
exploitable in DC vaccination strategies, in which DCs are educated ex vivo to present tumor …

Dendritic cell (DC)-based immunotherapy has been a promising strategy for colon cancer
therapy, but the efficacy of dendritic cell vaccines is in part limited by immunogenicity of …

The objective of this study was to evaluate some of the mechanisms involved in the
activation of the immune system in patients with advanced-stage cancer (n= 7) who received …

Dendritic cell-based immunotherapy is a promising strategy against cancer that appears to
be feasible, safe and to induce potent tumor-specific immune responses. The use of …

BACKGROUND: This study was conducted to test the efficacy of a new cancer vaccine,
composed of dendritic cells (DCs) pulsed with an interleukin-2 gene-encoded vaccinia virus …

Dendritic cells (DCs) are antigen presenting cells (APCs) in mammalian immune system.
They are also called as accessory cells. DCs are present in tissues that are in contact with …

Background: Dendritic cells (DCs) are the most important antigen-presenting cells in the
body and play a key role in antigen recognition, uptake, processing, and presentation and …

The discovery that dendritic cells (DC) play a key role in regulating antitumor immunity has
prompted considerable efforts in developing DC-based cancer vaccines for use in clinical …